Cogent Biosciences, Inc. (COGT)
30.32
-0.06
(-0.20%)
USD |
NASDAQ |
Oct 07, 12:07
Cogent Biosciences EPS Diluted (Quarterly) : -0.5636 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5636 |
| March 31, 2026 | -0.60 |
| December 31, 2025 | -0.6934 |
| September 30, 2025 | -0.588 |
| June 30, 2025 | -0.642 |
| March 31, 2025 | -0.5249 |
| December 31, 2024 | -0.6535 |
| September 30, 2024 | -0.6412 |
| June 30, 2024 | -0.594 |
| March 31, 2024 | -0.6149 |
| December 31, 2023 | -0.6268 |
| September 30, 2023 | -0.6427 |
| June 30, 2023 | -0.5896 |
| March 31, 2023 | -0.5455 |
| December 31, 2022 | -0.562 |
| September 30, 2022 | -0.5039 |
| June 30, 2022 | -0.7072 |
| March 31, 2022 | -0.6792 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.6112 |
| September 30, 2021 | -0.4789 |
| June 30, 2021 | -0.4305 |
| March 31, 2021 | -0.3362 |
| December 31, 2020 | -6.063 |
| September 30, 2020 | -5.074 |
| June 30, 2020 | -0.9506 |
| March 31, 2020 | -0.8088 |
| December 31, 2019 | 0.2945 |
| September 30, 2019 | -1.555 |
| June 30, 2019 | -1.379 |
| March 31, 2019 | -1.554 |
| December 31, 2018 | -1.145 |
| September 30, 2018 | -1.361 |
| June 30, 2018 | -1.238 |
| March 31, 2018 | -2.646 |
| December 31, 2017 | -0.88 |
| September 30, 2017 | -0.9206 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -1.965 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -96.40M |
| Total Expenses (Quarterly) | 96.40M |
| Enterprise Value | 4.731B |
| Earnings Yield | -8.06% |
| Normalized Earnings Yield | -7.952 |